Who owns Neoleukin Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Neoleukin Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Neoleukin Therapeutics stock

Who bought or sold Neoleukin Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of
Baker Bros. Advisors 3.8M $28M 0% Sep 2021
Redmile Group 3.5M $25M -11% Sep 2021
Vanguard Group 1.6M $12M 1% Sep 2021
Boxer Capital 1.5M $11M 0% Sep 2021
Opaleye Management 1.0M $7.6M -9% Sep 2021
Point72 Asset Management 1.0M $7.2M 13% Sep 2021
EcoR1 Capital 861k $6.2M -64% Sep 2021
Candriam Luxembourg S.C.A. 858k $0 68% Sep 2021
Renaissance Technologies 757k $5.5M 31% Sep 2021
Geode Capital Management 618k $4.5M 6% Sep 2021
State Street Corporation 610k $4.4M -51% Sep 2021

Setup an alert

Want to be notified whenever an investor makes a significant change to their holdings of Neoleukin Therapeutics?

Alkeon Capital Management 500k $3.6M 0% Sep 2021
Northern Trust 351k $2.5M -4% Sep 2021
Millennium Management 281k $2.0M 78% Sep 2021
ACT Capital Management 239k $1.7M 0% Sep 2021
Two Sigma Advisers 175k $1.3M 192% Sep 2021
Royce & Associates 145k $1.1M 0% Sep 2021
Nuveen Asset Management 140k $1.2M 0% Sep 2021
Granahan Investment Management 125k $906k -36% Sep 2021
Bank of New York Mellon 123k $887k 7% Sep 2021
Two Sigma Investments 120k $869k 208% Sep 2021
Charles Schwab Investment Management 89k $641k 0% Sep 2021
GSA Capital Partners 75k $545k 100% Sep 2021
Susquehanna International 75k $545k -47% Sep 2021
Swiss National Bank 74k $534k 0% Sep 2021
Hrt Financial 53k $382k 100% Sep 2021
California State Teachers Retirement System 49k $353k 0% Sep 2021
Highland Private Wealth Management 47k $340k 0% Sep 2021
Rhumbline Advisers 45k $328k -10% Sep 2021
Thomas Stevens, CFA" 43k $308k -8% Sep 2021
Sio Capital Management 38k $277k 0% Sep 2021
Trexquant Investment 34k $248k 141% Sep 2021
New York State Common Retirement Fund 34k $243k -28% Sep 2021
Alliancebernstein 26k $191k 0% Sep 2021
D. E. Shaw & Co 26k $189k 100% Sep 2021
Personal Cfo Solutions 25k $179k 4% Sep 2021
Clarius 24k $171k 0% Sep 2021
Dimensional Fund Advisors 23k $167k -38% Sep 2021
Citadel Advisors 22k $161k -89% Sep 2021
SG Americas Securities 22k $162k 100% Sep 2021
Deutsche Bank Aktiengesellschaft 22k $155k -3% Sep 2021
PDT Partners 21k $150k 100% Sep 2021
Janney Montgomery Scott 20k $145k 0% Sep 2021
Marshall Wace 19k $140k 100% Sep 2021
American International 19k $139k -2% Sep 2021
Florida State Board of Administration 19k $138k 0% Sep 2021
Credit Suisse 18k $127k 0% Sep 2021
T. Rowe Price Associates 16k $117k -55% Sep 2021
Invesco 16k $115k 13% Sep 2021
Nomura Holdings 16k $114k 0% Sep 2021
Oppenheimer & Co 15k $110k 7% Sep 2021
Ameriprise Financial 14k $120k 1% Sep 2021
Ing Investment Management 14k $103k 0% Sep 2021
ProShare Advisors 14k $98k -19% Sep 2021
Macquarie Group 12k $86k 2209% Sep 2021
Manufacturers Life Insurance Company 12k $84k -46% Sep 2021
ExodusPoint Capital Management 11k $82k -36% Sep 2021
Legal & General Group 11k $78k 159% Sep 2021
Ubs Global Asset Management Americas 10k $75k 0% Sep 2021
Wells Fargo & Company 9.6k $0 -20% Sep 2021
Metropolitan Life Insurance Company 4.7k $34k -52% Sep 2021
MetLife Investment Advisors 4.4k $32k -70% Sep 2021
Tower Research Capital 4.2k $31k 48% Sep 2021
UBS Group 4.1k $30k 2% Sep 2021
Cubist Systematic Strategies 3.9k $28k -29% Sep 2021
Great-West Life Assurance Company 2.8k $20k 0% Sep 2021
Summit Investment Advisors 2.6k $19k 0% Sep 2021
Advisor Group Holdings 1.5k $12k 50% Sep 2021
S.A.C. Capital Advisors 1.3k $10k -16% Sep 2021
Truvestments Capital 1.3k $10k 0% Sep 2021
Penserra Capital Management 970.00 $7.0k 1% Sep 2021
Signature 489.00 $4.0k 100% Sep 2021
Us Bancorp 164.00 $1.0k 100% Sep 2021
Daiwa Securities Group 79.00 $999.997800 0% Sep 2021
Parallel Advisors 53.00 $0 100% Sep 2021
Ellevest 24.00 $0 100% Sep 2021

Who sold out of Neoleukin Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Rafferty Asset Management Jun 2021 36k $335k
HPM Partners Jun 2021 31k $286k
Qube Research & Technologies Jun 2021 16k $151k
DekaBank Deutsche Girozentrale Jun 2021 14k $129k
Change Path Jun 2021 11k $97k
Eaton Vance Management Jun 2021 227.00 $2.0k
Geneos Wealth Management Jun 2021 215.00 $2.0k
Lindbrook Capital Sep 2021 39.00 $0